These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 33826984)

  • 1. Simple heteroaryl modifications in the 4,5-diarylisoxazol-3-carboxylic acid scaffold favorably modulates the activity as dual mPGES-1/5-LO inhibitors with in vivo efficacy.
    Gürses T; Olğaç A; Garscha U; Gür Maz T; Bal NB; Uludağ O; Çalışkan B; Schubert US; Werz O; Banoglu E
    Bioorg Chem; 2021 Jul; 112():104861. PubMed ID: 33826984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a benzenesulfonamide-based dual inhibitor of microsomal prostaglandin E
    Cheung SY; Werner M; Esposito L; Troisi F; Cantone V; Liening S; König S; Gerstmeier J; Koeberle A; Bilancia R; Rizza R; Rossi A; Roviezzo F; Temml V; Schuster D; Stuppner H; Schubert-Zsilavecz M; Werz O; Hanke T; Pace S
    Eur J Med Chem; 2018 Aug; 156():815-830. PubMed ID: 30053720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
    Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
    Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based screening for the discovery of 1,2,4-oxadiazoles as promising hits for the development of new anti-inflammatory agents interfering with eicosanoid biosynthesis pathways.
    Potenza M; Sciarretta M; Chini MG; Saviano A; Maione F; D'Auria MV; De Marino S; Giordano A; Hofstetter RK; Festa C; Werz O; Bifulco G
    Eur J Med Chem; 2021 Nov; 224():113693. PubMed ID: 34315041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel myrtucommulones and structural analogues that target mPGES-1 and 5-lipoxygenase.
    Wiechmann K; Müller H; Huch V; Hartmann D; Werz O; Jauch J
    Eur J Med Chem; 2015 Aug; 101():133-49. PubMed ID: 26123643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Combinatorial Virtual Screening Approach Driving the Synthesis of 2,4-Thiazolidinedione-Based Molecules as New Dual mPGES-1/5-LO Inhibitors.
    Lauro G; Terracciano S; Cantone V; Ruggiero D; Fischer K; Pace S; Werz O; Bruno I; Bifulco G
    ChemMedChem; 2020 Mar; 15(6):481-489. PubMed ID: 32022480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibitors of human mPGES-1 from structure-based computational screening.
    Zhou Z; Yuan Y; Zhou S; Ding K; Zheng F; Zhan CG
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3739-3743. PubMed ID: 28689972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and optimization of pyridyl-cycloalkyl-carboxylic acids as inhibitors of microsomal prostaglandin E synthase-1 for the treatment of endometriosis.
    Koppitz M; Bräuer N; Ter Laak A; Irlbacher H; Rotgeri A; Coelho AM; Walter D; Steinmeyer A; Zollner TM; Peters M; Nagel J
    Bioorg Med Chem Lett; 2019 Sep; 29(18):2700-2705. PubMed ID: 31362919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand-based Modeling for the Prediction of Pharmacophore Features for Multi-targeted Inhibition of the Arachidonic Acid Cascade.
    Saroj Devi N; Shanmugam R; Ghorai J; Ramanan M; Anbarasan P; Doble M
    Mol Inform; 2018 Mar; 37(3):. PubMed ID: 28991413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based, multi-targeted drug discovery approach to eicosanoid inhibition: Dual inhibitors of mPGES-1 and 5-lipoxygenase activating protein (FLAP).
    Ho JD; Lee MR; Rauch CT; Aznavour K; Park JS; Luz JG; Antonysamy S; Condon B; Maletic M; Zhang A; Hickey MJ; Hughes NE; Chandrasekhar S; Sloan AV; Gooding K; Harvey A; Yu XP; Kahl SD; Norman BH
    Biochim Biophys Acta Gen Subj; 2021 Feb; 1865(2):129800. PubMed ID: 33246032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rotational constriction of curcuminoids impacts 5-lipoxygenase and mPGES-1 inhibition and evokes a lipid mediator class switch in macrophages.
    Rao Z; Caprioglio D; Gollowitzer A; Kretzer C; Imperio D; Collado JA; Waltl L; Lackner S; Appendino G; Muñoz E; Temml V; Werz O; Minassi A; Koeberle A
    Biochem Pharmacol; 2022 Sep; 203():115202. PubMed ID: 35932797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Dual 5-Lipoxygenase/Microsomal Prostaglandin E2 Synthase-1 Inhibitory Effect of Natural and Synthetic Acronychia-Type Isoprenylated Acetophenones.
    Svouraki A; Garscha U; Kouloura E; Pace S; Pergola C; Krauth V; Rossi A; Sautebin L; Halabalaki M; Werz O; Gaboriaud-Kolar N; Skaltsounis AL
    J Nat Prod; 2017 Mar; 80(3):699-706. PubMed ID: 28240894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of 2-mercaptohexanoic acids as dual inhibitors of 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1.
    Greiner C; Zettl H; Koeberle A; Pergola C; Northoff H; Schubert-Zsilavecz M; Werz O
    Bioorg Med Chem; 2011 Jun; 19(11):3394-401. PubMed ID: 21570310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.
    Hanke T; Dehm F; Liening S; Popella SD; Maczewsky J; Pillong M; Kunze J; Weinigel C; Barz D; Kaiser A; Wurglics M; Lämmerhofer M; Schneider G; Sautebin L; Schubert-Zsilavecz M; Werz O
    J Med Chem; 2013 Nov; 56(22):9031-44. PubMed ID: 24171493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural products as inhibitors of prostaglandin E
    Koeberle A; Werz O
    Biotechnol Adv; 2018 Nov; 36(6):1709-1723. PubMed ID: 29454981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of pirinixic acid derivatives bearing a 2-aminothiazole moiety combines dual PPARα/γ activation and dual 5-LO/mPGES-1 inhibition.
    Hanke T; Lamers C; Gomez RC; Schneider G; Werz O; Schubert-Zsilavecz M
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3757-63. PubMed ID: 25037914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into the optimization of ethyl 5-hydroxybenzo[g]indol-3-carboxylates and their bioisosteric analogues as 5-LO/m-PGES-1 dual inhibitors able to suppress inflammation.
    Bruno F; Errico S; Pace S; Nawrozkij MB; Mkrtchyan AS; Guida F; Maisto R; Olgaç A; D'Amico M; Maione S; De Rosa M; Banoglu E; Werz O; Fiorentino A; Filosa R
    Eur J Med Chem; 2018 Jul; 155():946-960. PubMed ID: 30015253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel class of dual mPGES-1/5-LO inhibitors based on the α-naphthyl pirinixic acid scaffold.
    Hieke M; Greiner C; Thieme TM; Schubert-Zsilavecz M; Werz O; Zettl H
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1329-33. PubMed ID: 21310608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilic extracts of Leucas zeylanica, a multi-purpose medicinal plant in the tropics, inhibit key enzymes involved in inflammation and gout.
    Napagoda M; Gerstmeier J; Butschek H; Lorenz S; Kanatiwela D; Qader M; Nagahawatte A; De Soyza S; Wijayaratne GB; Svatoš A; Jayasinghe L; Koeberle A; Werz O
    J Ethnopharmacol; 2018 Oct; 224():474-481. PubMed ID: 29727733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of multi-target inhibitors of leukotriene and prostaglandin E
    Gür ZT; Çalışkan B; Garscha U; Olgaç A; Schubert US; Gerstmeier J; Werz O; Banoglu E
    Eur J Med Chem; 2018 Apr; 150():876-899. PubMed ID: 29597170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.